FDA to host meeting regarding ‘economically motivated adulteration’
WASHINGTON The Food and Drug Administration on May 1 will host a meeting around “economically motivated adulteration,” the association announced Monday through the Federal Register.
“The purpose of the meeting is to stimulate and focus a discussion about ways in which the food (including dietary supplements and animal food), drug, medical device and cosmetic industries, regulatory agencies and other parties can better predict and prevent economically motivated adulteration with a focus on situations that pose the greatest public health risk,” the agency stated.
CVS Caremark, HBCBSNJ reaches 5.5 million e-prescriptions
The news that CVS Caremark and Horizon Blue Cross Blue Shield of New Jersey have reached 5.5 million e-prescriptions since 2004 is no doubt a major example of how providers are increasingly communicating electronically to advance patient care. What’s even more impressive, is the number of e-prescriptions jumped 20% in just one year from 2007 to 2008.
Once again, CVS Caremark has proven to be a leader and on the forefront of technology, this time with its proprietary iScribe e-prescribing system.
As the article states, this technology not only translates into a cost-savings for patients but also a safety benefit as the system eliminates handwritten prescriptions and provides the prescriber with easy access to potentially harmful drug interaction information. Furthermore, it is no secret that adherence ? or rather lack thereof ? is a major issue within the industry but with iScribe physicians are alerted when a prescription has been unfilled.
Industry members would be wise to keep their eye on BCBSNJ as, according to CVS Caremark chief medical officer and EVP, Dr. Troyen Brennan, it is an “industry bellwether in using technology to improve safety and compliance for their patients.”
Alison Sweeney teams up with the APhA to help fellow allergy sufferers find relief
WASHINGTON The American Pharmacists Association and McNeil Consumer Healthcare Division on Thursday teamed with actress Alison Sweeney on the launch Behind the Counter Counts, a campaign designed to inform nasal congestion sufferers about pseudoephedrine treatment options located behind the pharmacy counter.
The new campaign features an online resource, www.BTCcenter.com, that features Sweeney’s personal tips, a tool to help people figure out if allergies or colds are causing their nasal congestion, and general information about PSE products.
“Congestion and other allergy symptoms can really get in the way when you’re juggling work, family and everyday life,” Sweeney stated. “I initially didn’t realize the medicines that I’ve relied on, Sudafed and Zyrtec-D … were located behind the pharmacy counter until I spoke with my pharmacist. That’s why I hope other allergy sufferers will do the same, because knowing what’s available and where to find it is the first step to finding the medicine that’s right for you.”